<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020045"><a href="http://purl.obolibrary.org/obo/MONDO_0020045">MONDO:0020045</a></h3>
<p><strong>Label:</strong> autosomal recessive cerebellar ataxia due to a DNA repair defect</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0011457">MONDO:0011457</a> (ataxia-telangiectasia-like disorder), <a href="http://purl.obolibrary.org/obo/MONDO_0008840">MONDO:0008840</a> (ataxia telangiectasia), <a href="http://purl.obolibrary.org/obo/MONDO_0018996">MONDO:0018996</a> (spinocerebellar ataxia with axonal neuropathy type 2), <a href="http://purl.obolibrary.org/obo/MONDO_0019600">MONDO:0019600</a> (xeroderma pigmentosum), <a href="http://purl.obolibrary.org/obo/MONDO_0016354">MONDO:0016354</a> (xeroderma pigmentosum-Cockayne syndrome complex),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_100">Orphanet:100</a>, <a href="http://purl.obolibrary.org/obo/OMIM_194400">OMIM:194400</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278780">OMIM:278780</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278760">OMIM:278760</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251347">Orphanet:251347</a>, <a href="http://www.orpha.net/ORDO/Orphanet_64753">Orphanet:64753</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208910">OMIM:208910</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615217">OMIM:615217</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610651">OMIM:610651</a>, <a href="http://purl.obolibrary.org/obo/OMIM_208900">OMIM:208900</a>, <a href="http://www.orpha.net/ORDO/Orphanet_220295">Orphanet:220295</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278700">OMIM:278700</a>, <a href="http://www.orpha.net/ORDO/Orphanet_910">Orphanet:910</a>, <a href="http://purl.obolibrary.org/obo/OMIM_606002">OMIM:606002</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278730">OMIM:278730</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278740">OMIM:278740</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604391">OMIM:604391</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278720">OMIM:278720</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0004334">HP:0004334</a> (Dermal atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0004334">HP:0004334</a> (Dermal atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0011355">HP:0011355</a> (Localized skin lesion) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0011354">HP:0011354</a> (Generalized abnormality of skin) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0011276">HP:0011276</a> (Vascular skin abnormality) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0008065">HP:0008065</a> (Aplasia/Hypoplasia of the skin) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0004334">HP:0004334</a> (Dermal atrophy) 63.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000504">HP:0000504</a> (Abnormality of vision) and <a href="http://purl.obolibrary.org/obo/HP_0001029">HP:0001029</a> (Poikiloderma) and <a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 63.89%</li>
</ul>
</body>
</html>
